Statements Author contributions YFF and YL contributed to the conceptual design, writing, editing, and generation of figures for this manuscript
Herzenberg LA, De Rosa SC, Dubs JG, et al
To increase the chances of finding therapeutic signals and regulatory success, pharmaceutical makers running clinical studies need to make sure that the peptides they choose are in line with the criteria for inclusion and the endpoints they set
We therefore screened the effect of BPC 157 on tendon fibroblasts by cDNA microarray analysis in our previous study
A systematic review focusing on the link between engineered nanoparticles and neurodegeneration
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a protein found in human gastric juice